title: (68)Ga small peptide imaging: comparison of NOTA and PCTA.
abstract: In this study, a bifunctional version of the chelate PCTA was compared to the analogous NOTA derivative for peptide conjugation, (68)Ga radiolabeling, and small peptide imaging. Both p-SCN-Bn-PCTA and p-SCN-Bn-NOTA were conjugated to cyclo-RGDyK. The resulting conjugates, PCTA-RGD and NOTA-RGD, retained their affinity for the peptide target, the α(v)β(3) receptor. Both PCTA-RGD and NOTA-RGD could be radiolabeled with (68)Ga in >95% radiochemical yield (RCY) at room temperature within 5 min. For PCTA-RGD, higher effective specific activities, up to 55 MBq/nmol, could be achieved in 95% RCY with gentle heating at 40 °C. The (68)Ga-radiolabeled conjugates were >90% stable in serum and in the presence of excess apo-transferrin over 4 h; (68)Ga-PCTA-RGD did have slightly lower stability than (68)Ga-NOTA-RGD, 93 ± 2% compared to 98 ± 1%, at the 4 h time point. Finally, the tumor and nontarget organ uptake and clearance of (68)Ga-radiolabeled PCTA-RGD and NOTA-RGD was compared in mice bearing HT-29 colorectal tumor xenografts. Activity cleared quickly from the blood and muscle tissue with >90% and >70% of the initial activity cleared within the first 40 min, respectively. The majority of activity was observed in the kidney, liver, and tumor tissue. The observed tumor uptake was specific with up to 75% of the tumor uptake blocked when the mice were preinjected with 160 nmol (100 μg) of unlabeled peptide. Uptake observed in the blocked tumors was not significantly different than the background activity observed in muscle tissue. The only significant difference between the two (68)Ga-radiolabeled bioconjugates in vivo was the kidney uptake. (68)Ga-radiolabeled PCTA-RGD had significantly lower (p < 0.05) kidney uptake (1.1 ± 0.5%) at 2 h postinjection compared to (68)Ga-radiolabeled NOTA-RGD (2.7 ± 1.3%). Overall, (68)Ga-radiolabeled PCTA-RGD and NOTA-RGD performed similarly, but the lower kidney uptake for (68)Ga-radiolabeled PCTA-RGD may be advantageous in some imaging applications.
authors.affiliation: Nordion, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada, V6T 2A3. cara.ferreira@nordion.com
authors.forename: Cara L
authors.initials: CL
authors.lastname: Ferreira
authors.forename: Donald T T
authors.initials: DT
authors.lastname: Yapp
authors.forename: Derek
authors.initials: D
authors.lastname: Mandel
authors.forename: Rajanvir K
authors.initials: RK
authors.lastname: Gill
authors.forename: Eszter
authors.initials: E
authors.lastname: Boros
authors.forename: May Q
authors.initials: MQ
authors.lastname: Wong
authors.forename: Paul
authors.initials: P
authors.lastname: Jurek
authors.forename: Garry E
authors.initials: GE
authors.lastname: Kiefer
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D002722:Chlorobenzenes / Q000737:chemistry / Q000493:pharmacokinetics; D005710:Gallium Radioisotopes; D006571:Heterocyclic Compounds / Q000737:chemistry / Q000493:pharmacokinetics; D006573:Heterocyclic Compounds, 1-Ring; D006801:Humans; D051379:Mice; D057054:Molecular Imaging / Q000379:methods*; D015394:Molecular Structure; D009842:Oligopeptides / Q000737:chemistry / Q000493:pharmacokinetics; D049268:Positron-Emission Tomography; D014018:Tissue Distribution
chemical_list: D002722:Chlorobenzenes; D005710:Gallium Radioisotopes; D006571:Heterocyclic Compounds; D006573:Heterocyclic Compounds, 1-Ring; D009842:Oligopeptides; C048993:1,4,7-triazacyclononane-N,N',N''-triacetic acid; C047981:arginyl-glycyl-aspartic acid; C031281:pentachloromethylthiobenzene